The Immunology and Inflammation Core was established in 2010 as a new compo""""""""nent ofthe University of Washington's Diabetes Research Center with the goal of establishing a resource offering state-of-the-art flow cytometry services for the Center's affiliate investigators. To meet this need, the Core's specific aims are to: (1) Provide cost-effective state-of-the-art flow cytometry-related services to characterize and isolate (a) Tand B-lymphocytes and their subpopulations from blood of humans and mice;(b) T- and B-lymphocytes, and myeloid cell populations (macrophages, neutrophils, dendritic cells) from adipose tissue of humans and mice;(c) endothelial cells from several different mouse tissues;and (d) mouse islet endocrine cell populations;(2) Develop new flow cytometry-related techniques to meet affiliate investigators'needs, including development of custom monoclonal antibodies;(3) Provide expert training ih flow cytometry principals and techniques;and (4) Provide consultation in planning, performance, and troubleshooting of flow cytometry analyses. Little more than a year in existence, the core has already provided services to 24 affiliate investigators, which includes the isolation of mouse islet endothelial cells, the'isolation of lymphocytes from mice, and the characterization and isolation of adipose tissue leukcjcyte populations in both humans and mice. Thus, the Immunology and Inflammation Core facilitates and enhances the research of Diabetes Research Center affiliate investigators by providing expertise and state-of-the-art equipment to perform flow cytometry and related techniques that would not otherwise be available to them.
The Immunology and Inflammation Core is a recently established core that uses state-of-the-art equipment and provides the necessary expertise to offer Diabetes Research Center affiliate investigators flow cytometry services.
|Auerbach, Brandon J; Dibey, Sepideh; Vallila-Buchman, Petra et al. (2018) Review of 100% Fruit Juice and Chronic Health Conditions: Implications for Sugar-Sweetened Beverage Policy. Adv Nutr 9:78-85|
|Wang, Yang; Sosinowski, Tomasz; Novikov, Andrey et al. (2018) C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes. Proc Natl Acad Sci U S A 115:162-167|
|Kikuchi, Shinsuke; Chen, Lihua; Xiong, Kevin et al. (2018) Smooth muscle cells of human veins show an increased response to injury at valve sites. J Vasc Surg 67:1556-1570.e9|
|Erickson, Michelle A; Banks, William A (2018) Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions. Pharmacol Rev 70:278-314|
|Parilla, Jacqueline H; Hull, Rebecca L; Zraika, Sakeneh (2018) Neprilysin Deficiency Is Associated With Expansion of Islet ?-Cell Mass in High Fat-Fed Mice. J Histochem Cytochem 66:523-530|
|Writing Group for the TRIGR Study Group; Knip, Mikael; Åkerblom, Hans K et al. (2018) Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. JAMA 319:38-48|
|Solan, Joell L; Lampe, Paul D (2018) Spatio-temporal regulation of connexin43 phosphorylation and gap junction dynamics. Biochim Biophys Acta Biomembr 1860:83-90|
|Howard, Barbara V; Aragaki, Aaron K; Tinker, Lesley F et al. (2018) A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women's Health Initiative Dietary Modification Trial. Diabetes Care 41:680-687|
|RISE Consortium (2018) Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: II. Observations Using the Oral Glucose Tolerance Test. Diabetes Care 41:1707-1716|
|Norris, Jill M; Lee, Hye-Seung; Frederiksen, Brittni et al. (2018) Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes 67:146-154|
Showing the most recent 10 out of 1296 publications